Halozyme Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
HALO | B | Halozyme Therapeutics, Inc. | 1.38 | |
NXTC | C | NextCure, Inc. | 4.67 |
Related Industries: Biotechnology
Related Stock Lists:
Biopharmaceutical
Solid Tumors
Antibodies
Biotechnology
Cancer
Cancer Treatment
Clinical Development
Clinical Medicine
Clinical Trial Product
Diabetes
Diabetes Mellitus
Enzymes
Hoffmann La Roche
Hyaluronidase
Immune Related Diseases
Immunotherapy
Insulin
Intrexon
Life Sciences
Medicine
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
FBT | B | First Trust Amex Biotech Index Fund | 4.22 | |
FFLS | A | The Future Fund Long/Short ETF | 4.17 | |
FFND | A | The Future Fund Active ETF | 3.78 | |
PBE | B | PowerShares Dynamic Biotech & Genome | 3.17 | |
SCAP | A | InfraCap Small Cap Income ETF | 2.42 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Biopharmaceutical
Solid Tumors
Antibodies
Biotechnology
Cancer
Cancer Treatment
Clinical Development
Clinical Medicine
Clinical Trial Product
Diabetes
Diabetes Mellitus
Enzymes
Hoffmann La Roche
Hyaluronidase
Immune Related Diseases
Immunotherapy
Insulin
Intrexon
Life Sciences
Medicine
- Halozyme
Halozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles